Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 309 articles:
HTML format
Text format



Single Articles


    January 2014
  1. ARANCIBIA S, Espinoza C, Salazar F, Del Campo M, et al
    A Novel Immunomodulatory Hemocyanin from the Limpet Fissurella latimarginata Promotes Potent Anti-Tumor Activity in Melanoma.
    PLoS One. 2014;9:e87240.
    PubMed     Text format     Related articles    Abstract available


  2. PAL HC, Sharma S, Strickland LR, Katiyar SK, et al
    Fisetin Inhibits Human Melanoma Cell Invasion through Promotion of Mesenchymal to Epithelial Transition and by Targeting MAPK and NFkappaB Signaling Pathways.
    PLoS One. 2014;9:e86338.
    PubMed     Text format     Related articles    Abstract available


  3. JANOTOVA T, Jalovecka M, Auerova M, Svecova I, et al
    The use of anchored agonists of phagocytic receptors for cancer immunotherapy: b16-f10 murine melanoma model.
    PLoS One. 2014;9:e85222.
    PubMed     Text format     Related articles    Abstract available


  4. NEMATI F, de Montrion C, Lang G, Kraus-Berthier L, et al
    Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts.
    PLoS One. 2014;9:e80836.
    PubMed     Text format     Related articles    Abstract available


  5. MENZIES AM, Haydu LE, Carlino MS, Azer MW, et al
    Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.
    PLoS One. 2014;9:e85004.
    PubMed     Text format     Related articles    Abstract available


  6. KEDRACKA-KROK S, Jankowska U, Elas M, Sowa U, et al
    Proteomic analysis of proton beam irradiated human melanoma cells.
    PLoS One. 2014;9:e84621.
    PubMed     Text format     Related articles    Abstract available


  7. BELANGER F, Rajotte V, Drobetsky EA
    A Majority of Human Melanoma Cell Lines Exhibits an S Phase-Specific Defect in Excision of UV-Induced DNA Photoproducts.
    PLoS One. 2014;9:e85294.
    PubMed     Text format     Related articles    Abstract available


  8. HOUBEN R, Schmid CP, Maier M, Wobser M, et al
    p53 Regulation by TRP2 Is Not Pervasive in Melanoma.
    PLoS One. 2014;9:e87440.
    PubMed     Text format     Related articles    Abstract available


  9. PANCOSKA P, Kirkwood JM, Bouros S, Spyropoulou-Vlachou M, et al
    A new mathematical model for the interpretation of translational research evaluating six ctla-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon.
    PLoS One. 2014;9:e86375.
    PubMed     Text format     Related articles    Abstract available


  10. MECKBACH D, Bauer J, Pflugfelder A, Meier F, et al
    Survival According to BRAF-V600 Tumor Mutations - An Analysis of 437 Patients with Primary Melanoma.
    PLoS One. 2014;9:e86194.
    PubMed     Text format     Related articles    Abstract available


  11. TARHINI AA, Edington H, Butterfield LH, Lin Y, et al
    Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.
    PLoS One. 2014;9:e87705.
    PubMed     Text format     Related articles    Abstract available


  12. SORENSEN MR, Pedersen SR, Lindkvist A, Christensen JP, et al
    Quantification of B16 Melanoma Cells in Lungs Using Triplex Q-PCR - A New Approach to Evaluate Melanoma Cell Metastasis and Tumor Control.
    PLoS One. 2014;9:e87831.
    PubMed     Text format     Related articles    Abstract available


  13. MIRKINA I, Hadzijusufovic E, Krepler C, Mikula M, et al
    Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R.
    PLoS One. 2014;9:e84417.
    PubMed     Text format     Related articles    Abstract available


  14. FEDERICI C, Petrucci F, Caimi S, Cesolini A, et al
    Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin.
    PLoS One. 2014;9:e88193.
    PubMed     Text format     Related articles    Abstract available


  15. CHANG L, Pei J, Li C, Zhang P, et al
    Incidence and Metastasis of Cutaneous Malignant Melanoma with Respect to ABO Blood Groups: A Case-Controlled Study in Northeast of China.
    PLoS One. 2014;9:e88096.
    PubMed     Text format     Related articles    Abstract available


  16. PEITSCH WK, Doerflinger Y, Fischer-Colbrie R, Huck V, et al
    Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.
    PLoS One. 2014;9:e89491.
    PubMed     Text format     Related articles    Abstract available


  17. CHATTOPADHYAY C, Grimm EA, Woodman SE
    Simultaneous Inhibition of the HGF/MET and Erk1/2 Pathways Affect Uveal Melanoma Cell Growth and Migration.
    PLoS One. 2014;9:e83957.
    PubMed     Text format     Related articles    Abstract available


  18. SZTILLER-SIKORSKA M, Koprowska K, Majchrzak K, Hartman M, et al
    Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells.
    PLoS One. 2014;9:e90783.
    PubMed     Text format     Related articles    Abstract available


  19. MCMURPHY T, Xiao R, Magee D, Slater A, et al
    The anti-tumor activity of a neutralizing nanobody targeting leptin receptor in a mouse model of melanoma.
    PLoS One. 2014;9:e89895.
    PubMed     Text format     Related articles    Abstract available


  20. UMEMURA M, Baljinnyam E, Feske S, De Lorenzo MS, et al
    Store-Operated Ca(2) (+) Entry (SOCE) Regulates Melanoma Proliferation and Cell Migration.
    PLoS One. 2014;9:e89292.
    PubMed     Text format     Related articles    Abstract available


  21. MECKBACH D, Keim U, Richter S, Leiter U, et al
    BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy.
    PLoS One. 2014;9:e89218.
    PubMed     Text format     Related articles    Abstract available


  22. GUNGOR B, Gombos I, Crul T, Ayaydin F, et al
    Rac1 Participates in Thermally Induced Alterations of the Cytoskeleton, Cell Morphology and Lipid Rafts, and Regulates the Expression of Heat Shock Proteins in B16F10 Melanoma Cells.
    PLoS One. 2014;9:e89136.
    PubMed     Text format     Related articles    Abstract available


  23. MORRIS JC, Tan AR, Olencki TE, Shapiro GI, et al
    Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFbeta) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma.
    PLoS One. 2014;9:e90353.
    PubMed     Text format     Related articles    Abstract available


  24. HALDER K, Banerjee S, Bose A, Majumder S, et al
    Overexpressed PKCdelta Downregulates the Expression of PKCalpha in B16F10 Melanoma: Induction of Apoptosis by PKCdelta via Ceramide Generation.
    PLoS One. 2014;9:e91656.
    PubMed     Text format     Related articles    Abstract available


  25. QI CL, Wei B, Ye J, Yang Y, et al
    P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells.
    PLoS One. 2014;9:e91320.
    PubMed     Text format     Related articles    Abstract available


  26. KIM HS, Kim TJ, Yoo YM
    Melatonin Combined with Endoplasmic Reticulum Stress Induces Cell Death via the PI3K/Akt/mTOR Pathway in B16F10 Melanoma Cells.
    PLoS One. 2014;9:e92627.
    PubMed     Text format     Related articles    Abstract available


  27. TALONI A, Alemi AA, Ciusani E, Sethna JP, et al
    Mechanical properties of growing melanocytic nevi and the progression to melanoma.
    PLoS One. 2014;9:e94229.
    PubMed     Text format     Related articles    Abstract available


  28. FARZAN SF, Karagas MR, Christensen BC, Li Z, et al
    RNASEL and MIR146A SNP-SNP Interaction as a Susceptibility Factor for Non-Melanoma Skin Cancer.
    PLoS One. 2014;9:e93602.
    PubMed     Text format     Related articles    Abstract available


  29. OLSEN CM, Knight LL, Green AC
    Risk of Melanoma in People with HIV/AIDS in the Pre- and Post-HAART Eras: A Systematic Review and Meta-Analysis of Cohort Studies.
    PLoS One. 2014;9:e95096.
    PubMed     Text format     Related articles    Abstract available


  30. CHIEN AJ, Haydu LE, Biechele TL, Kulikauskas RM, et al
    Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/beta-Catenin Signaling.
    PLoS One. 2014;9:e94748.
    PubMed     Text format     Related articles    Abstract available


  31. HARTMAN ML, Talar B, Noman MZ, Gajos-Michniewicz A, et al
    Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype.
    PLoS One. 2014;9:e95157.
    PubMed     Text format     Related articles    Abstract available


  32. LI R, Zhang L, Jia L, Duan Y, et al
    MicroRNA-143 Targets Syndecan-1 to Repress Cell Growth in Melanoma.
    PLoS One. 2014;9:e94855.
    PubMed     Text format     Related articles    Abstract available


  33. FUJITA Y, Koinuma S, De Velasco MA, Bolz J, et al
    Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.
    PLoS One. 2014;9:e94772.
    PubMed     Text format     Related articles    Abstract available


  34. MACAULAY EC, Roberts HE, Cheng X, Jeffs AR, et al
    Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene.
    PLoS One. 2014;9:e95840.
    PubMed     Text format     Related articles    Abstract available


  35. AGUILAR-GUZMAN L, Lobos-Gonzalez L, Rosas C, Vallejos G, et al
    Human Survivin and Trypanosoma cruzi Calreticulin Act in Synergy against a Murine Melanoma In Vivo.
    PLoS One. 2014;9:e95457.
    PubMed     Text format     Related articles    Abstract available


  36. SALAMON J, Hoffmann T, Elies E, Peldschus K, et al
    Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice.
    PLoS One. 2014;9:e95822.
    PubMed     Text format     Related articles    Abstract available


  37. PENG HY, Lin CC, Wang HY, Shih Y, et al
    The Melanogenesis Alteration Effects of Achillea millefolium L. Essential Oil and Linalyl Acetate: Involvement of Oxidative Stress and the JNK and ERK Signaling Pathways in Melanoma Cells.
    PLoS One. 2014;9:e95186.
    PubMed     Text format     Related articles    Abstract available


  38. ARROYO-BERDUGO Y, Alonso S, Ribas G, Ibarrola-Villava M, et al
    Involvement of ANXA5 and ILKAP in Susceptibility to Malignant Melanoma.
    PLoS One. 2014;9:e95522.
    PubMed     Text format     Related articles    Abstract available


  39. PEREIRA FV, Ferreira-Guimaraes CA, Paschoalin T, Scutti JA, et al
    A Natural Bacterial-Derived Product, the Metalloprotease Arazyme, Inhibits Metastatic Murine Melanoma by Inducing MMP-8 Cross-Reactive Antibodies.
    PLoS One. 2014;9:e96141.
    PubMed     Text format     Related articles    Abstract available


  40. FOFARIA NM, Kim SH, Srivastava SK
    Piperine Causes G1 Phase Cell Cycle Arrest and Apoptosis in Melanoma Cells through Checkpoint Kinase-1 Activation.
    PLoS One. 2014;9:e94298.
    PubMed     Text format     Related articles    Abstract available


  41. OBRADOR E, Valles SL, Benlloch M, Sirerol JA, et al
    Glucocorticoid Receptor Knockdown Decreases the Antioxidant Protection of B16 Melanoma Cells: An Endocrine System-Related Mechanism that Compromises Metastatic Cell Resistance to Vascular Endothelium-Induced Tumor Cytotoxicity.
    PLoS One. 2014;9:e96466.
    PubMed     Text format     Related articles    Abstract available


  42. REDMER T, Welte Y, Behrens D, Fichtner I, et al
    The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells.
    PLoS One. 2014;9:e92596.
    PubMed     Text format     Related articles    Abstract available


  43. ECSEDI S, Hernandez-Vargas H, Lima SC, Vizkeleti L, et al
    DNA methylation characteristics of primary melanomas with distinct biological behaviour.
    PLoS One. 2014;9:e96612.
    PubMed     Text format     Related articles    Abstract available


  44. NASPI A, Panasiti V, Abbate F, Roberti V, et al
    Insulin-Like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression In Vitro and In Vivo.
    PLoS One. 2014;9:e98641.
    PubMed     Text format     Related articles    Abstract available


  45. RIBEIRO-PEREIRA C, Moraes JA, Souza Mde J, Laurindo FR, et al
    Redox Modulation of FAK Controls Melanoma Survival - Role of NOX4.
    PLoS One. 2014;9:e99481.
    PubMed     Text format     Related articles    Abstract available


  46. REES JR, Zens MS, Gui J, Celaya MO, et al
    Non melanoma skin cancer and subsequent cancer risk.
    PLoS One. 2014;9:e99674.
    PubMed     Text format     Related articles    Abstract available


  47. CHEN J, Li L, Su J, Li B, et al
    Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin.
    PLoS One. 2014;9:e101277.
    PubMed     Text format     Related articles    Abstract available


  48. LI R, Zhang L, Jia L, Duan Y, et al
    Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation.
    PLoS One. 2014;9:e100893.
    PubMed     Text format     Related articles    Abstract available


  49. AOUDE LG, Xu M, Zhao ZZ, Kovacs M, et al
    Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene.
    PLoS One. 2014;9:e100683.
    PubMed     Text format     Related articles    Abstract available


  50. PENN LA, Qian M, Zhang E, Ng E, et al
    Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance.
    PLoS One. 2014;9:e101507.
    PubMed     Text format     Related articles    Abstract available



  51. Correction: Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy.
    PLoS One. 2014;9:e101732.
    PubMed     Text format     Related articles    Abstract available


  52. YAMAMOTO S, Hotta MM, Okochi M, Honda H, et al
    Effect of Vascular Formed Endothelial Cell Network on the Invasive Capacity of Melanoma Using the In Vitro 3D Co-Culture Patterning Model.
    PLoS One. 2014;9:e103502.
    PubMed     Text format     Related articles    Abstract available


  53. YANG J, Bill MA, Young GS, La Perle K, et al
    Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells.
    PLoS One. 2014;9:e102983.
    PubMed     Text format     Related articles    Abstract available


  54. ZHANG YP, Chu RX, Liu H
    Vitamin a intake and risk of melanoma: a meta-analysis.
    PLoS One. 2014;9:e102527.
    PubMed     Text format     Related articles    Abstract available


  55. KLEEMANN B, Loos B, Scriba TJ, Lang D, et al
    St John's Wort (Hypericum perforatum L.) Photomedicine: Hypericin-Photodynamic Therapy Induces Metastatic Melanoma Cell Death.
    PLoS One. 2014;9:e103762.
    PubMed     Text format     Related articles    Abstract available


  56. VILELA FM, Syed DN, Chamcheu JC, Calvo-Castro LA, et al
    Biotransformed Soybean Extract (BSE) Inhibits Melanoma Cell Growth and Viability In Vitro: Involvement of Nuclear Factor-Kappa B Signaling.
    PLoS One. 2014;9:e103248.
    PubMed     Text format     Related articles    Abstract available


  57. LOPEZ S, Garcia O, Yurrebaso I, Flores C, et al
    The Interplay between Natural Selection and Susceptibility to Melanoma on Allele 374F of SLC45A2 Gene in a South European Population.
    PLoS One. 2014;9:e104367.
    PubMed     Text format     Related articles    Abstract available



  58. Correction: The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells.
    PLoS One. 2014;9:e105274.
    PubMed     Text format     Related articles    Abstract available


  59. EDELE F, Dudda JC, Bachtanian E, Jakob T, et al
    Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route.
    PLoS One. 2014;9:e105266.
    PubMed     Text format     Related articles    Abstract available


  60. SLUIJTER M, van der Sluis TC, van der Velden PA, Versluis M, et al
    Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy.
    PLoS One. 2014;9:e104230.
    PubMed     Text format     Related articles    Abstract available


  61. KANG S, Kim JE, Song NR, Jung SK, et al
    The Ginsenoside 20-O-beta-D-Glucopyranosyl-20(S)-Protopanaxadiol Induces Autophagy and Apoptosis in Human Melanoma via AMPK/JNK Phosphorylation.
    PLoS One. 2014;9:e104305.
    PubMed     Text format     Related articles    Abstract available


  62. ASNAGHI L, Lin MH, Lim KS, Lim KJ, et al
    Hypoxia Promotes Uveal Melanoma Invasion through Enhanced Notch and MAPK Activation.
    PLoS One. 2014;9:e105372.
    PubMed     Text format     Related articles    Abstract available


  63. MIGNOT G, Hervieu A, Vabres P, Dalac S, et al
    Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients.
    PLoS One. 2014;9:e105907.
    PubMed     Text format     Related articles    Abstract available


  64. NOTEBAERT L, Chrystal J, Clarke PJ, Holmes EA, et al
    When we should worry more: using cognitive bias modification to drive adaptive health behaviour.
    PLoS One. 2014;9:e85092.
    PubMed     Text format     Related articles    Abstract available


  65. ZHAO K, Wei L, Hui H, Dai Q, et al
    Wogonin suppresses melanoma cell b16-f10 invasion and migration by inhibiting ras-medicated pathways.
    PLoS One. 2014;9:e106458.
    PubMed     Text format     Related articles    Abstract available


  66. CURL P, Vujic I, van 't Veer LJ, Ortiz-Urda S, et al
    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma.
    PLoS One. 2014;9:e107255.
    PubMed     Text format     Related articles    Abstract available


  67. HARARI D, Abramovich R, Zozulya A, Smith P, et al
    Bridging the species divide: transgenic mice humanized for type-I interferon response.
    PLoS One. 2014;9:e84259.
    PubMed     Text format     Related articles    Abstract available


  68. WEIDERT E, Pohler SE, Gomez EW, Dong C, et al
    Actinomyosin Contraction, Phosphorylation of VE-Cadherin, and Actin Remodeling Enable Melanoma-Induced Endothelial Cell-Cell Junction Disassembly.
    PLoS One. 2014;9:e108092.
    PubMed     Text format     Related articles    Abstract available


  69. CAPASSO D, de Paola I, Liguoro A, Del Gatto A, et al
    RGDechi-hCit: alphavbeta3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells.
    PLoS One. 2014;9:e106441.
    PubMed     Text format     Related articles    Abstract available


  70. BABAPOOR S, Fleming E, Wu R, Dadras SS, et al
    A Novel miR-451a isomiR, Associated with Amelanotypic Phenotype, Acts as a Tumor Suppressor in Melanoma by Retarding Cell Migration and Invasion.
    PLoS One. 2014;9:e107502.
    PubMed     Text format     Related articles    Abstract available


  71. XU X, Wei WB, Li B, Gao F, et al
    Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese.
    PLoS One. 2014;9:e109699.
    PubMed     Text format     Related articles    Abstract available


  72. WILLIAMS RT, Barnhill LM, Kuo HH, Lin WD, et al
    Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
    PLoS One. 2014;9:e88219.
    PubMed     Text format     Related articles    Abstract available


  73. MONTURIOL-GROSS L, Flores-Diaz M, Pineda-Padilla MJ, Castro-Castro AC, et al
    Clostridium perfringens phospholipase C induced ROS production and cytotoxicity require PKC, MEK1 and NFkappaB activation.
    PLoS One. 2014;9:e86475.
    PubMed     Text format     Related articles    Abstract available


  74. LINSLEY PS, Speake C, Whalen E, Chaussabel D, et al
    Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis.
    PLoS One. 2014;9:e109760.
    PubMed     Text format     Related articles    Abstract available


  75. TROMME I, Devleesschauwer B, Beutels P, Richez P, et al
    Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi.
    PLoS One. 2014;9:e109339.
    PubMed     Text format     Related articles    Abstract available


    January 2013
  76. LOPEZ-RIOS F , Angulo B, Gomez B, Mair D, et al
    Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib.
    PLoS One. 2013;8:e53733.
    PubMed     Text format     Related articles    Abstract available


  77. MACHADO D , Shishido SM, Queiroz KC, Oliveira DN, et al
    Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo.
    PLoS One. 2013;8:e54269.
    PubMed     Text format     Related articles    Abstract available


  78. BUSCH C , Krochmann J, Drews U
    The chick embryo as an experimental system for melanoma cell invasion.
    PLoS One. 2013;8:e53970.
    PubMed     Text format     Related articles    Abstract available


  79. RASO-BARNETT L , Banky B, Barbai T, Becsagh P, et al
    Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression.
    PLoS One. 2013;8:e53883.
    PubMed     Text format     Related articles    Abstract available


  80. VOSKENS CJ , Goldinger SM, Loquai C, Robert C, et al
    The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network.
    PLoS One. 2013;8:e53745.
    PubMed     Text format     Related articles    Abstract available


  81. ONDRUSOVA L , Vachtenheim J, Reda J, Zakova P, et al
    MITF-Independent Pro-Survival Role of BRG1-Containing SWI/SNF Complex in Melanoma Cells.
    PLoS One. 2013;8:e54110.
    PubMed     Text format     Related articles    Abstract available


  82. XIE X , White EP, Mehnert JM
    Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma.
    PLoS One. 2013;8:e55096.
    PubMed     Text format     Related articles    Abstract available


  83. RAKOSY Z , Ecsedi S, Toth R, Vizkeleti L, et al
    Integrative genomics identifies gene signature associated with melanoma ulceration.
    PLoS One. 2013;8:e54958.
    PubMed     Text format     Related articles    Abstract available


  84. FERNANDEZ-CABEZUDO MJ , El-Kharrag R, Torab F, Bashir G, et al
    Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model.
    PLoS One. 2013;8:e55993.
    PubMed     Text format     Related articles    Abstract available


  85. STEFANAKI I , Panagiotou OA, Kodela E, Gogas H, et al
    Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study.
    PLoS One. 2013;8:e55712.
    PubMed     Text format     Related articles    Abstract available


  86. WU X , Marmarelis ME, Hodi FS
    Activity of the heat shock protein 90 inhibitor ganetespib in melanoma.
    PLoS One. 2013;8:e56134.
    PubMed     Text format     Related articles    Abstract available


  87. ITZHAKI O , Greenberg E, Shalmon B, Kubi A, et al
    Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.
    PLoS One. 2013;8:e57160.
    PubMed     Text format     Related articles    Abstract available


  88. DEL BELLO B , Toscano M, Moretti D, Maellaro E, et al
    Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells.
    PLoS One. 2013;8:e57236.
    PubMed     Text format     Related articles    Abstract available


  89. FELLI N , Felicetti F, Lustri AM, Errico MC, et al
    miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma.
    PLoS One. 2013;8:e56824.
    PubMed     Text format     Related articles    Abstract available


  90. ZHAO Y , Zhang D, Wang S, Tao L, et al
    Holothurian Glycosaminoglycan Inhibits Metastasis and Thrombosis via Targeting of Nuclear Factor-kappaB/Tissue Factor/Factor Xa Pathway in Melanoma B16F10 Cells.
    PLoS One. 2013;8:e56557.
    PubMed     Text format     Related articles    Abstract available


  91. SCHREIBER C , Kuch V, Umansky V, Sleeman JP, et al
    Autochthonous Mouse Melanoma and Mammary Tumors do not Express the Pluripotency Genes Oct4 and Nanog.
    PLoS One. 2013;8:e57465.
    PubMed     Text format     Related articles    Abstract available


  92. KORNER R , Preuss KD, Fadle N, Madjidi D, et al
    Serum Antibodies against CD28- A New Potential Marker of Dismal Prognosis in Melanoma Patients.
    PLoS One. 2013;8:e58087.
    PubMed     Text format     Related articles    Abstract available


  93. JANEK T , Krasowska A, Radwanska A, Lukaszewicz M, et al
    Lipopeptide Biosurfactant Pseudofactin II Induced Apoptosis of Melanoma A 375 Cells by Specific Interaction with the Plasma Membrane.
    PLoS One. 2013;8:e57991.
    PubMed     Text format     Related articles    Abstract available


  94. BESSER MJ , Shoham T, Harari-Steinberg O, Zabari N, et al
    Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies.
    PLoS One. 2013;8:e57922.
    PubMed     Text format     Related articles    Abstract available


  95. SALAMA AK , de Rosa N, Scheri RP, Pruitt SK, et al
    Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy.
    PLoS One. 2013;8:e57665.
    PubMed     Text format     Related articles    Abstract available


  96. TSAI HE , Wu JC, Kung ML, Liu LF, et al
    Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma.
    PLoS One. 2013;8:e59345.
    PubMed     Text format     Related articles    Abstract available


  97. FAIAO-FLORES F , Coelho PR, Toledo Arruda-Neto JD, Maria-Engler SS, et al
    Apoptosis through Bcl-2/Bax and Cleaved Caspase Up-Regulation in Melanoma Treated by Boron Neutron Capture Therapy.
    PLoS One. 2013;8:e59639.
    PubMed     Text format     Related articles    Abstract available


  98. DESAI BM , Villanueva J, Nguyen TT, Lioni M, et al
    The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling.
    PLoS One. 2013;8:e59588.
    PubMed     Text format     Related articles    Abstract available


  99. PENA-CHILET M , Ibarrola-Villava M, Martin-Gonzalez M, Feito M, et al
    rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility.
    PLoS One. 2013;8:e59607.
    PubMed     Text format     Related articles    Abstract available


  100. RAIMBOURG Q , Perez J, Vandermeersch S, Prignon A, et al
    The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma.
    PLoS One. 2013;8:e60469.
    PubMed     Text format     Related articles    Abstract available


  101. CHACON JA , Wu RC, Sukhumalchandra P, Molldrem JJ, et al
    Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8(+) Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy.
    PLoS One. 2013;8:e60031.
    PubMed     Text format     Related articles    Abstract available


  102. HOJJAT-FARSANGI M , Ghaemimanesh F, Daneshmanesh AH, Bayat AA, et al
    Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells.
    PLoS One. 2013;8:e61167.
    PubMed     Text format     Related articles    Abstract available


  103. STRUH CM , Jager S, Kersten A, Schempp CM, et al
    Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine b16.f10 melanoma in vivo.
    PLoS One. 2013;8:e62168.
    PubMed     Text format     Related articles    Abstract available


  104. WEIDE B , Faller C, Buttner P, Pflugfelder A, et al
    Prognostic Factors of Melanoma Patients with Satellite or In-Transit Metastasis at the Time of Stage III Diagnosis.
    PLoS One. 2013;8:e63137.
    PubMed     Text format     Related articles    Abstract available


  105. SURDU S , Fitzgerald EF, Bloom MS, Boscoe FP, et al
    Occupational exposure to ultraviolet radiation and risk of non-melanoma skin cancer in a multinational European study.
    PLoS One. 2013;8:e62359.
    PubMed     Text format     Related articles    Abstract available


  106. RAKOSY Z , Ecsedi S, Toth R, Vizkeleti L, et al
    Correction: Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration.
    PLoS One. 2013;8.
    PubMed     Text format     Related articles    Abstract available


  107. KRELIN Y , Berkovich L, Amit M, Gil Z, et al
    Association between Tumorigenic Potential and the Fate of Cancer Cells in a Syngeneic Melanoma Model.
    PLoS One. 2013;8:e62124.
    PubMed     Text format     Related articles    Abstract available


  108. BIRON-PAIN K , Grosset AA, Poirier F, Gaboury L, et al
    Expression and functions of galectin-7 in human and murine melanomas.
    PLoS One. 2013;8:e63307.
    PubMed     Text format     Related articles    Abstract available


  109. DILLENBURG-PILLA P , Maria AG, Reis RI, Floriano EM, et al
    Activation of the kinin b1 receptor attenuates melanoma tumor growth and metastasis.
    PLoS One. 2013;8:e64453.
    PubMed     Text format     Related articles    Abstract available


  110. REXHEPAJ E , Agnarsdottir M, Bergman J, Edqvist PH, et al
    A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections.
    PLoS One. 2013;8:e62070.
    PubMed     Text format     Related articles    Abstract available


  111. CIFOLA I , Pietrelli A, Consolandi C, Severgnini M, et al
    Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
    PLoS One. 2013;8:e63597.
    PubMed     Text format     Related articles    Abstract available


  112. BALLAS ZK , Buchta CM, Rosean TR, Heusel JW, et al
    Role of NK cell subsets in organ-specific murine melanoma metastasis.
    PLoS One. 2013;8:e65599.
    PubMed     Text format     Related articles    Abstract available


  113. ZHANG C , Yang C, Wang R, Jiao Y, et al
    c-Abl Kinase Is a Regulator of alphabeta Integrin Mediated Melanoma A375 Cell Migration.
    PLoS One. 2013;8:e66108.
    PubMed     Text format     Related articles    Abstract available


  114. WEIDE B , Faller C, Elsasser M, Buttner P, et al
    Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour.
    PLoS One. 2013;8:e66953.
    PubMed     Text format     Related articles    Abstract available


  115. LAZOVA R , Laberge GS, Duvall E, Spoelstra N, et al
    A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer.
    PLoS One. 2013;8:e66731.
    PubMed     Text format     Related articles    Abstract available


  116. TSCHANDL P , Berghoff AS, Preusser M, Burgstaller-Muehlbacher S, et al
    NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi.
    PLoS One. 2013;8:e69639.
    PubMed     Text format     Related articles    Abstract available


  117. LOQUAI C , Scheurich V, Syring N, Schmidtmann I, et al
    Screening for distress in routine oncological care-a survey in 520 melanoma patients.
    PLoS One. 2013;8:e66800.
    PubMed     Text format     Related articles    Abstract available


  118. TOOMEY P , Kodumudi K, Weber A, Kuhn L, et al
    Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer.
    PLoS One. 2013;8:e68561.
    PubMed     Text format     Related articles    Abstract available


  119. ZIMMERMAN ZF , Kulikauskas RM, Bomsztyk K, Moon RT, et al
    Activation of Wnt/beta-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail.
    PLoS One. 2013;8:e69593.
    PubMed     Text format     Related articles    Abstract available


  120. HAYATA K , Iwahashi M, Ojima T, Katsuda M, et al
    Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.
    PLoS One. 2013;8:e53131.
    PubMed     Text format     Related articles    Abstract available


  121. SEIDENARI S , Arginelli F, Dunsby C, French PM, et al
    Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics.
    PLoS One. 2013;8:e70682.
    PubMed     Text format     Related articles    Abstract available


  122. DEL BELLO B , Toscano M, Moretti D, Maellaro E, et al
    Correction: Cisplatin-Induced Apoptosis Inhibits Autophagy, Which Acts as a Pro-Survival Mechanism in Human Melanoma Cells.
    PLoS One. 2013;8.
    PubMed     Text format     Related articles    Abstract available


  123. BOWDEN NA , Ashton KA, Vilain RE, Avery-Kiejda KA, et al
    Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.
    PLoS One. 2013;8:e70424.
    PubMed     Text format     Related articles    Abstract available


  124. XIONG WH , Duvoisin RM, Adamus G, Jeffrey BG, et al
    Serum TRPM1 Autoantibodies from Melanoma Associated Retinopathy Patients Enter Retinal ON-Bipolar Cells and Attenuate the Electroretinogram in Mice.
    PLoS One. 2013;8:e69506.
    PubMed     Text format     Related articles    Abstract available


  125. KUMAR S , Sharma P, Kumar D, Chakraborty G, et al
    Functional characterization of stromal osteopontin in melanoma progression and metastasis.
    PLoS One. 2013;8:e69116.
    PubMed     Text format     Related articles    Abstract available


  126. BEAR AS , Kennedy LC, Young JK, Perna SK, et al
    Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer.
    PLoS One. 2013;8:e69073.
    PubMed     Text format     Related articles    Abstract available


  127. JALILI A , Mertz KD, Romanov J, Wagner C, et al
    NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo.
    PLoS One. 2013;8:e69064.
    PubMed     Text format     Related articles    Abstract available


  128. QU Y , Wang Y, Ma J, Zhang Y, et al
    Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.
    PLoS One. 2013;8:e68724.
    PubMed     Text format     Related articles    Abstract available


  129. TSAI HE , Wu JC, Kung ML, Liu LF, et al
    Correction: Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma.
    PLoS One. 2013;8.
    PubMed     Text format     Related articles    Abstract available


  130. RAMIREZ-GARCIA A , Arteta B, Abad-Diaz-de-Cerio A, Pellon A, et al
    Candida albicans Increases Tumor Cell Adhesion to Endothelial Cells In Vitro: Intraspecific Differences and Importance of the Mannose Receptor.
    PLoS One. 2013;8:e53584.
    PubMed     Text format     Related articles    Abstract available


  131. AOUDE LG , Wadt K, Bojesen A, Cruger D, et al
    A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers.
    PLoS One. 2013;8:e72144.
    PubMed     Text format     Related articles    Abstract available


  132. BOURSAULT L , Haddad V, Vergier B, Cappellen D, et al
    Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing.
    PLoS One. 2013;8:e70826.
    PubMed     Text format     Related articles    Abstract available


  133. CHAPMAN CH , Nazem-Zadeh M, Lee OE, Schipper MJ, et al
    Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics.
    PLoS One. 2013;8:e57768.
    PubMed     Text format     Related articles    Abstract available


  134. BURKE LS , Hyland PL, Pfeiffer RM, Prescott J, et al
    Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations.
    PLoS One. 2013;8:e71121.
    PubMed     Text format     Related articles    Abstract available


  135. KASHANI-SABET M , Sagebiel RW, Joensuu H, Miller JR 3rd, et al
    A patient-centered methodology that improves the accuracy of prognostic predictions in cancer.
    PLoS One. 2013;8:e56435.
    PubMed     Text format     Related articles    Abstract available


  136. CAMPBELL AD , Lawn S, McGarry LC, Welch HC, et al
    P-Rex1 cooperates with PDGFRbeta to drive cellular migration in 3D microenvironments.
    PLoS One. 2013;8:e53982.
    PubMed     Text format     Related articles    Abstract available


  137. DANHIER P , Copetti T, De Preter G, Leveque P, et al
    Influence of cell detachment on the respiration rate of tumor and endothelial cells.
    PLoS One. 2013;8:e53324.
    PubMed     Text format     Related articles    Abstract available


  138. LAL G , Contreras PG, Kulak M, Woodfield G, et al
    Human Melanoma Cells Over-Express Extracellular Matrix 1 (ECM1) Which Is Regulated by TFAP2C.
    PLoS One. 2013;8:e73953.
    PubMed     Text format     Related articles    Abstract available


  139. KOZUBEK J , Ma Z, Fleming E, Duggan T, et al
    In-Depth Characterization of microRNA Transcriptome in Melanoma.
    PLoS One. 2013;8:e72699.
    PubMed     Text format     Related articles    Abstract available


  140. TAHIRI A , Roe K, Ree AH, de Wijn R, et al
    Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma.
    PLoS One. 2013;8:e72692.
    PubMed     Text format     Related articles    Abstract available


  141. MA J , Han H, Liu D, Li W, et al
    HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy.
    PLoS One. 2013;8:e73261.
    PubMed     Text format     Related articles    Abstract available


  142. HAO J , Shi FD, Abdelwahab M, Shi SX, et al
    Nicotinic Receptor beta2 Determines NK Cell-Dependent Metastasis in a Murine Model of Metastatic Lung Cancer.
    PLoS One. 2013;8:e57495.
    PubMed     Text format     Related articles    Abstract available


  143. AHN JO , Lee HW, Seo KW, Kang SK, et al
    Anti-Tumor Effect of Adipose Tissue Derived-Mesenchymal Stem Cells Expressing Interferon-beta and Treatment with Cisplatin in a Xenograft Mouse Model for Canine Melanoma.
    PLoS One. 2013;8:e74897.
    PubMed     Text format     Related articles    Abstract available


  144. MARGUE C , Philippidou D, Reinsbach SE, Schmitt M, et al
    New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion.
    PLoS One. 2013;8:e73473.
    PubMed     Text format     Related articles    Abstract available


  145. MANDEL Y , Laufer S, Belkin M, Rubinsky B, et al
    Irreversible electroporation of human primary uveal melanoma in enucleated eyes.
    PLoS One. 2013;8:e71789.
    PubMed     Text format     Related articles    Abstract available


  146. CHANDRA S , Barth RF, Haider SA, Yang W, et al
    Biodistribution and Subcellular Localization of an Unnatural Boron-Containing Amino Acid (Cis-ABCPC) by Imaging Secondary Ion Mass Spectrometry for Neutron Capture Therapy of Melanomas and Gliomas.
    PLoS One. 2013;8:e75377.
    PubMed     Text format     Related articles    Abstract available


  147. JALILI A , Mertz KD, Romanov J, Wagner C, et al
    Correction: NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth and
    PLoS One. 2013;8.
    PubMed     Text format     Related articles    Abstract available


  148. SKOROKHOD A , Helmbold P, Brors B, Schirmacher P, et al
    Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).
    PLoS One. 2013;8:e59221.
    PubMed     Text format     Related articles    Abstract available


  149. BOBINET M , Vignard V, Florenceau L, Lang F, et al
    Overexpression of Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation.
    PLoS One. 2013;8:e75421.
    PubMed     Text format     Related articles    Abstract available


  150. CARBONNELLE D , Vignard V, Sehedic D, Moreau-Aubry A, et al
    The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Polycistronic mRNA Containing Functional IRES Sequences.
    PLoS One. 2013;8:e75233.
    PubMed     Text format     Related articles    Abstract available


  151. ROTTE A , Bhandaru M, Cheng Y, Sjoestroem C, et al
    Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients.
    PLoS One. 2013;8:e75405.
    PubMed     Text format     Related articles    Abstract available


  152. NICHOLAS C , Yang J, Peters SB, Bill MA, et al
    PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27
    PLoS One. 2013;8:e74710.
    PubMed     Text format     Related articles    Abstract available


  153. MA J , Han H, Liu D, Li W, et al
    Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy.
    PLoS One. 2013;8.
    PubMed     Text format     Related articles    Abstract available


  154. WOUTERS J , Stas M, Gremeaux L, Govaere O, et al
    The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis.
    PLoS One. 2013;8:e76550.
    PubMed     Text format     Related articles    Abstract available


  155. PIETRASZEK K , Brezillon S, Perreau C, Malicka-Blaszkiewicz M, et al
    Lumican - Derived Peptides Inhibit Melanoma Cell Growth and Migration.
    PLoS One. 2013;8:e76232.
    PubMed     Text format     Related articles    Abstract available


  156. GONIN J , Carlotti A, Dietrich C, Audebourg A, et al
    Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas.
    PLoS One. 2013;8:e75694.
    PubMed     Text format     Related articles    Abstract available


  157. CHIBA Y , Mizoguchi I, Mitobe K, Higuchi K, et al
    IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner.
    PLoS One. 2013;8:e76159.
    PubMed     Text format     Related articles    Abstract available


  158. SOKHI UK , Bacolod MD, Dasgupta S, Emdad L, et al
    Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPase(old-35) ) Using Melanoma as a Model.
    PLoS One. 2013;8:e76284.
    PubMed     Text format     Related articles    Abstract available


  159. IBARRONDO FJ , Yang OO, Chodon T, Avramis E, et al
    Natural killer T cells in advanced melanoma patients treated with tremelimumab.
    PLoS One. 2013;8:e76829.
    PubMed     Text format     Related articles    Abstract available


  160. GANDINI S , De Vries E, Tosti G, Botteri E, et al
    Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy.
    PLoS One. 2013;8:e78820.
    PubMed     Text format     Related articles    Abstract available


  161. PANDEY MK , Gowda K, Doi K, Sharma AK, et al
    Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells.
    PLoS One. 2013;8:e78570.
    PubMed     Text format     Related articles    Abstract available


  162. FREGNI G , Messaoudene M, Fourmentraux-Neves E, Mazouz-Dorval S, et al
    Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
    PLoS One. 2013;8:e76928.
    PubMed     Text format     Related articles    Abstract available


  163. BERGAMO P , Cocca E, Palumbo R, Gogliettino M, et al
    RedOx Status, Proteasome and APEH: Insights into Anticancer Mechanisms of t10,c12-Conjugated Linoleic Acid Isomer on A375 Melanoma Cells.
    PLoS One. 2013;8:e80900.
    PubMed     Text format     Related articles    Abstract available


  164. BUSS S , Dobra J, Goerg K, Hoffmann S, et al
    Visible Light Is a Better Co-Inducer of Apoptosis for Curcumin-Treated Human Melanoma Cells than UVA.
    PLoS One. 2013;8:e79748.
    PubMed     Text format     Related articles    Abstract available


  165. SJOESTROEM C , Khosravi S, Zhang G, Martinka M, et al
    C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients.
    PLoS One. 2013;8:e80492.
    PubMed     Text format     Related articles    Abstract available


  166. GONIN J , Carlotti A, Dietrich C, Audebourg A, et al
    Correction: Expression of IL-27 by Tumor Cells in Invasive Cutaneous and Metastatic Melanomas.
    PLoS One. 2013;8.
    PubMed     Text format     Related articles    Abstract available


  167. WEIDE B, Richter S, Buttner P, Leiter U, et al
    Serum S100B, Lactate Dehydrogenase and Brain Metastasis Are Prognostic Factors in Patients with Distant Melanoma Metastasis and Systemic Therapy.
    PLoS One. 2013;8:e81624.
    PubMed     Text format     Related articles    Abstract available


  168. DAHMKE IN, Backes C, Rudzitis-Auth J, Laschke MW, et al
    Curcumin Intake Affects miRNA Signature in Murine Melanoma with mmu-miR-205-5p Most Significantly Altered.
    PLoS One. 2013;8:e81122.
    PubMed     Text format     Related articles    Abstract available


  169. CANUEL M, Sun X, Asselin MC, Paramithiotis E, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1).
    PLoS One. 2013;8:e64145.
    PubMed     Text format     Related articles    Abstract available


  170. BAKER M, Reynolds LE, Robinson SD, Lees DM, et al
    Stromal Claudin14-heterozygosity, but not deletion, increases tumour blood leakage without affecting tumour growth.
    PLoS One. 2013;8:e62516.
    PubMed     Text format     Related articles    Abstract available


  171. CANNUYER J, Loriot A, Parvizi GK, De Smet C, et al
    Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications.
    PLoS One. 2013;8:e58743.
    PubMed     Text format     Related articles    Abstract available


  172. WROBLEWSKI D, Jiang CC, Croft A, Farrelly ML, et al
    OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis.
    PLoS One. 2013;8:e84073.
    PubMed     Text format     Related articles    Abstract available


  173. KELKKA T, Pizzolla A, Laurila JP, Friman T, et al
    Mice Lacking NCF1 Exhibit Reduced Growth of Implanted Melanoma and Carcinoma Tumors.
    PLoS One. 2013;8:e84148.
    PubMed     Text format     Related articles    Abstract available


  174. MOLOGNONI F, de Melo FH, da Silva CT, Jasiulionis MG, et al
    Ras and rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate dnmt1 level and are causally related to melanocyte malignant transformation.
    PLoS One. 2013;8:e81937.
    PubMed     Text format     Related articles    Abstract available


  175. FANG S, Han J, Zhang M, Wang LE, et al
    Joint Effect of Multiple Common SNPs Predicts Melanoma Susceptibility.
    PLoS One. 2013;8:e85642.
    PubMed     Text format     Related articles    Abstract available


  176. CUBILLO E, Diaz-Lopez A, Cuevas EP, Moreno-Bueno G, et al
    E47 and Id1 interplay in epithelial-mesenchymal transition.
    PLoS One. 2013;8:e59948.
    PubMed     Text format     Related articles    Abstract available


  177. DEO M, Huang JL, Van Raamsdonk CD
    Genetic interactions between neurofibromin and endothelin receptor B in mice.
    PLoS One. 2013;8:e59931.
    PubMed     Text format     Related articles    Abstract available


  178. WALLNER S, Lutz-Nicoladoni C, Tripp CH, Gastl G, et al
    The role of the e3 ligase cbl-B in murine dendritic cells.
    PLoS One. 2013;8:e65178.
    PubMed     Text format     Related articles    Abstract available


  179. JENSEN BA, Pedersen SR, Christensen JP, Thomsen AR, et al
    The availability of a functional tumor targeting T-cell repertoire determines the anti-tumor efficiency of combination therapy with anti-CTLA-4 and anti-4-1BB antibodies.
    PLoS One. 2013;8:e66081.
    PubMed     Text format     Related articles    Abstract available


  180. KAWAHARA H, Naito H, Takara K, Wakabayashi T, et al
    Tumor endothelial cell-specific drug delivery system using apelin-conjugated liposomes.
    PLoS One. 2013;8:e65499.
    PubMed     Text format     Related articles    Abstract available


  181. XIAO J , Zhang G, Qiu P, Liu X, et al
    Tanshinone IIA Increases the Bystander Effect of Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy via Enhanced Gap Junctional Intercellular Communication.
    PLoS One. 2013;8:e67662.
    PubMed     Text format     Related articles    Abstract available


  182. KING AJ, Arnone MR, Bleam MR, Moss KG, et al
    Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions.
    PLoS One. 2013;8:e67583.
    PubMed     Text format     Related articles    Abstract available


  183. KOMINE H, Kuhn L, Matsushita N, Mule JJ, et al
    Examination of MARCO activity on dendritic cell phenotype and function using a gene knockout mouse.
    PLoS One. 2013;8:e67795.
    PubMed     Text format     Related articles    Abstract available


  184. GOTTFRIED E, Lang SA, Renner K, Bosserhoff A, et al
    New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.
    PLoS One. 2013;8:e66987.
    PubMed     Text format     Related articles    Abstract available


  185. YANG CH, Yue J, Sims M, Pfeffer LM, et al
    The curcumin analog EF24 targets NF-kappaB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
    PLoS One. 2013;8:e71130.
    PubMed     Text format     Related articles    Abstract available


  186. GOTTSCHALK S, Yu F, Ji M, Kakarla S, et al
    A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.
    PLoS One. 2013;8:e82658.
    PubMed     Text format     Related articles    Abstract available


    January 2012
  187. TALEBIAN F , Liu JQ, Liu Z, Khattabi M, et al
    Melanoma Cell Expression of CD200 Inhibits Tumor Formation and Lung Metastasis via Inhibition of Myeloid Cell Functions.
    PLoS One. 2012;7:e31442.
    PubMed     Text format     Related articles    Abstract available


  188. XU K , Mao X, Mehta M, Cui J, et al
    A Comparative Study of Gene-Expression Data of Basal Cell Carcinoma and Melanoma Reveals New Insights about the Two Cancers.
    PLoS One. 2012;7:e30750.
    PubMed     Text format     Related articles    Abstract available


  189. SENFT D , Berking C, Graf SA, Kammerbauer C, et al
    Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1.
    PLoS One. 2012;7:e30821.
    PubMed     Text format     Related articles    Abstract available


  190. MEI HF , Jin XB, Zhu JY, Zeng AH, et al
    beta-defensin 2 as an Adjuvant Promotes Anti-Melanoma Immune Responses and Inhibits the Growth of Implanted Murine Melanoma In Vivo.
    PLoS One. 2012;7:e31328.
    PubMed     Text format     Related articles    Abstract available


  191. SEONG I , Min HJ, Lee JH, Yeo CY, et al
    Sox10 Controls Migration of B16F10 Melanoma Cells through Multiple Regulatory Target Genes.
    PLoS One. 2012;7:e31477.
    PubMed     Text format     Related articles    Abstract available


  192. POURREYRON C , Reilly L, Proby C, Panteleyev A, et al
    Wnt5a Is Strongly Expressed at the Leading Edge in Non-Melanoma Skin Cancer, Forming Active Gradients, while Canonical Wnt Signalling Is Repressed.
    PLoS One. 2012;7:e31827.
    PubMed     Text format     Related articles    Abstract available


  193. MERVIC L
    Time Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women.
    PLoS One. 2012;7:e32955.
    PubMed     Text format     Related articles    Abstract available


  194. LEE EY , Park KS, Yoon YJ, Lee J, et al
    Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis.
    PLoS One. 2012;7:e33330.
    PubMed     Text format     Related articles    Abstract available


  195. FERNANDEZ-BARRAL A , Orgaz JL, Gomez V, Del Peso L, et al
    Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent Mechanism.
    PLoS One. 2012;7:e32989.
    PubMed     Text format     Related articles    Abstract available


  196. CHAKRABORTY G , Kumar S, Mishra R, Patil TV, et al
    Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model.
    PLoS One. 2012;7:e33633.
    PubMed     Text format     Related articles    Abstract available


  197. MIHIC-PROBST D , Ikenberg K, Tinguely M, Schraml P, et al
    Tumor cell plasticity and angiogenesis in human melanomas.
    PLoS One. 2012;7:e33571.
    PubMed     Text format     Related articles    Abstract available


  198. LIANG G , Nan H, Qureshi AA, Han J, et al
    Pre-diagnostic plasma 25-hydroxyvitamin d levels and risk of non-melanoma skin cancer in women.
    PLoS One. 2012;7:e35211.
    PubMed     Text format     Related articles    Abstract available


  199. JELLBAUER S , Panthel K, Hetrodt JH, Russmann H, et al
    CD8 T-Cell Induction against Vascular Endothelial Growth Factor Receptor 2 by Salmonella for Vaccination Purposes against a Murine Melanoma.
    PLoS One. 2012;7:e34214.
    PubMed     Text format     Related articles    Abstract available


  200. TRAGER U , Sierro S, Djordjevic G, Bouzo B, et al
    The immune response to melanoma is limited by thymic selection of self-antigens.
    PLoS One. 2012;7:e35005.
    PubMed     Text format     Related articles    Abstract available


  201. LOVLY CM , Dahlman KB, Fohn LE, Su Z, et al
    Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
    PLoS One. 2012;7:e35309.
    PubMed     Text format     Related articles    Abstract available


  202. WANG L , Hurley DG, Watkins W, Araki H, et al
    Cell cycle gene networks are associated with melanoma prognosis.
    PLoS One. 2012;7:e34247.
    PubMed     Text format     Related articles    Abstract available


  203. GUAN H , Singh NP, Singh UP, Nagarkatti PS, et al
    Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma.
    PLoS One. 2012;7:e35650.
    PubMed     Text format     Related articles    Abstract available


  204. GARCIA MP , Cavalheiro JR, Fernandes MH
    Acute and long-term effects of hyperthermia in b16-f10 melanoma cells.
    PLoS One. 2012;7:e35489.
    PubMed     Text format     Related articles    Abstract available


  205. LUIZ OC , Gianini RJ, Goncalves FT, Francisco G, et al
    Ethnicity and cutaneous melanoma in the city of sao paulo, Brazil: a case-control study.
    PLoS One. 2012;7:e36348.
    PubMed     Text format     Related articles    Abstract available


  206. MAJOR JM , Kiruthu C, Weinstein SJ, Horst RL, et al
    Pre-diagnostic circulating vitamin d and risk of melanoma in men.
    PLoS One. 2012;7:e35112.
    PubMed     Text format     Related articles    Abstract available


  207. NJAUW CN , Kim I, Piris A, Gabree M, et al
    Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families.
    PLoS One. 2012;7:e35295.
    PubMed     Text format     Related articles    Abstract available


  208. SONG JK , Park MH, Choi DY, Yoo HS, et al
    Deficiency of C-C Chemokine Receptor 5 Suppresses Tumor Development via Inactivation of NF-kappaB and Upregulation of IL-1Ra in Melanoma Model.
    PLoS One. 2012;7:e33747.
    PubMed     Text format     Related articles    Abstract available


  209. GANGEMI R , Mirisola V, Barisione G, Fabbi M, et al
    Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    PLoS One. 2012;7:e29989.
    PubMed     Text format     Related articles    Abstract available


  210. VURGESE S , Panda-Jonas S, Jonas JB
    Scleral thickness in human eyes.
    PLoS One. 2012;7:e29692.
    PubMed     Text format     Related articles    Abstract available


  211. YANCOVITZ M , Litterman A, Yoon J, Ng E, et al
    Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma.
    PLoS One. 2012;7:e29336.
    PubMed     Text format     Related articles    Abstract available


  212. BLACKMAN RK , Cheung-Ong K, Gebbia M, Proia DA, et al
    Mitochondrial electron transport is the cellular target of the oncology drug elesclomol.
    PLoS One. 2012;7:e29798.
    PubMed     Text format     Related articles    Abstract available


  213. WU X , Zhu M, Fletcher JA, Giobbie-Hurder A, et al
    The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
    PLoS One. 2012;7:e29622.
    PubMed     Text format     Related articles    Abstract available


  214. CHO HR , Choi SH, Lee N, Hyeon T, et al
    Macrophages homing to metastatic lymph nodes can be monitored with ultrasensitive ferromagnetic iron-oxide nanocubes and a 1.5T clinical MR scanner.
    PLoS One. 2012;7:e29575.
    PubMed     Text format     Related articles    Abstract available


  215. SCHMIDT J , Riechers A, Stoll R, Amann T, et al
    Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition.
    PLoS One. 2012;7:e37941.
    PubMed     Text format     Related articles    Abstract available


  216. ELSAESSER O , Leiter U, Buettner PG, Eigentler TK, et al
    Prognosis of sentinel node staged patients with primary cutaneous melanoma.
    PLoS One. 2012;7:e29791.
    PubMed     Text format     Related articles    Abstract available


  217. MEYER S , Fuchs TJ, Bosserhoff AK, Hofstadter F, et al
    A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.
    PLoS One. 2012;7:e38222.
    PubMed     Text format     Related articles    Abstract available


  218. CHARTRAIN M , Riond J, Stennevin A, Vandenberghe I, et al
    Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells.
    PLoS One. 2012;7:e36762.
    PubMed     Text format     Related articles    Abstract available


  219. LEBBE C , Guedj M, Basset-Seguin N, Podgorniak MP, et al
    A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling.
    PLoS One. 2012;7:e29143.
    PubMed     Text format     Related articles    Abstract available


  220. LIU X , Fang H, Chen H, Jiang X, et al
    An Artificial miRNA against HPSE Suppresses Melanoma Invasion Properties, Correlating with a Down-Regulation of Chemokines and MAPK Phosphorylation.
    PLoS One. 2012;7:e38659.
    PubMed     Text format     Related articles    Abstract available


  221. SCHUSTER C , Eikesdal HP, Puntervoll H, Geisler J, et al
    Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.
    PLoS One. 2012;7:e38364.
    PubMed     Text format     Related articles    Abstract available


  222. MAGNUSSEN GI , Holm R, Emilsen E, Rosnes AK, et al
    High expression of wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.
    PLoS One. 2012;7:e38254.
    PubMed     Text format     Related articles    Abstract available


  223. MASSAOKA MH , Matsuo AL, Figueiredo CR, Farias CF, et al
    Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo.
    PLoS One. 2012;7:e38698.
    PubMed     Text format     Related articles    Abstract available


  224. QUAST SA , Berger A, Buttstadt N, Friebel K, et al
    General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC.
    PLoS One. 2012;7:e39290.
    PubMed     Text format     Related articles    Abstract available


  225. SHIPP C , Derhovanessian E, Pawelec G
    Effect of culture at low oxygen tension on the expression of heat shock proteins in a panel of melanoma cell lines.
    PLoS One. 2012;7:e37475.
    PubMed     Text format     Related articles    Abstract available


  226. JANNIE KM , Stipp CS, Weiner JA
    ALCAM Regulates Motility, Invasiveness, and Adherens Junction Formation in Uveal Melanoma Cells.
    PLoS One. 2012;7:e39330.
    PubMed     Text format     Related articles    Abstract available


  227. BARRIO MM , Abes R, Colombo M, Pizzurro G, et al
    Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells.
    PLoS One. 2012;7:e40311.
    PubMed     Text format     Related articles    Abstract available


  228. SIMONSEN TG , Gaustad JV, Leinaas MN, Rofstad EK, et al
    High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts.
    PLoS One. 2012;7:e40006.
    PubMed     Text format     Related articles    Abstract available


  229. MUEHLEISEN B , Jiang SB, Gladsjo JA, Gerber M, et al
    Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.
    PLoS One. 2012;7:e40754.
    PubMed     Text format     Related articles    Abstract available


  230. HO AL , Musi E, Ambrosini G, Nair JS, et al
    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.
    PLoS One. 2012;7:e40439.
    PubMed     Text format     Related articles    Abstract available


  231. CLAWSON GA , Kimchi E, Patrick SD, Xin P, et al
    Circulating tumor cells in melanoma patients.
    PLoS One. 2012;7:e41052.
    PubMed     Text format     Related articles    Abstract available


  232. O'DONNELL EF , Kopparapu PR, Koch DC, Jang HS, et al
    The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.
    PLoS One. 2012;7:e40926.
    PubMed     Text format     Related articles    Abstract available


  233. LIANG Z , Zhan W, Zhu A, Yoon Y, et al
    Development of a unique small molecule modulator of CXCR4.
    PLoS One. 2012;7:e34038.
    PubMed     Text format     Related articles    Abstract available


  234. JIAO Y , Feng X, Zhan Y, Wang R, et al
    Matrix metalloproteinase-2 Promotes alphavbeta3 Integrin-Mediated Adhesion and Migration of Human Melanoma Cells by Cleaving Fibronectin.
    PLoS One. 2012;7:e41591.
    PubMed     Text format     Related articles    Abstract available


  235. YAN D , Dong XD, Chen X, Yao S, et al
    Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2.
    PLoS One. 2012;7:e40967.
    PubMed     Text format     Related articles    Abstract available


  236. SWEET M , Kirkham N, Bendall M, Currey L, et al
    Evidence of melanoma in wild marine fish populations.
    PLoS One. 2012;7:e41989.
    PubMed     Text format     Related articles    Abstract available


  237. CHEN B , Tardell C, Higgins B, Packman K, et al
    BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines.
    PLoS One. 2012;7:e42598.
    PubMed     Text format     Related articles    Abstract available


  238. SHULL AY , Latham-Schwark A, Ramasamy P, Leskoske K, et al
    Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma.
    PLoS One. 2012;7:e43369.
    PubMed     Text format     Related articles    Abstract available


  239. MURRAY LB , Lau YK, Yu Q
    Merlin is a negative regulator of human melanoma growth.
    PLoS One. 2012;7:e43295.
    PubMed     Text format     Related articles    Abstract available


  240. BARBI DE MOURA M , Vincent G, Fayewicz SL, Bateman NW, et al
    Mitochondrial respiration - an important therapeutic target in melanoma.
    PLoS One. 2012;7:e40690.
    PubMed     Text format     Related articles    Abstract available


  241. WANG E , Zhao Y, Monaco A, Uccellini L, et al
    A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
    PLoS One. 2012;7:e40805.
    PubMed     Text format     Related articles    Abstract available


  242. FENOUILLE N , Tichet M, Dufies M, Pottier A, et al
    The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion.
    PLoS One. 2012;7:e40378.
    PubMed     Text format     Related articles    Abstract available


  243. BILL MA , Nicholas C, Mace TA, Etter JP, et al
    Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines.
    PLoS One. 2012;7:e40724.
    PubMed     Text format     Related articles    Abstract available


  244. CHENG Y , Sk UH, Zhang Y, Ren X, et al
    Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
    PLoS One. 2012;7:e35104.
    PubMed     Text format     Related articles    Abstract available


  245. POELL JB , van Haastert RJ, de Gunst T, Schultz IJ, et al
    A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability.
    PLoS One. 2012;7:e43569.
    PubMed     Text format     Related articles    Abstract available


  246. HINTERLEITNER R , Gruber T, Pfeifhofer-Obermair C, Lutz-Nicoladoni C, et al
    Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model.
    PLoS One. 2012;7:e44295.
    PubMed     Text format     Related articles    Abstract available


  247. MUNIR S , Larsen SK, Iversen TZ, Donia M, et al
    Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
    PLoS One. 2012;7:e34568.
    PubMed     Text format     Related articles    Abstract available


  248. BRASSART-PASCO S , Senechal K, Thevenard J, Ramont L, et al
    Tetrastatin, the NC1 domain of the alpha4(IV) collagen chain: a novel potent anti-tumor matrikine.
    PLoS One. 2012;7:e29587.
    PubMed     Text format     Related articles    Abstract available


  249. DE SOUZA CF , Xander P, Monteiro AC, Silva AG, et al
    Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
    PLoS One. 2012;7:e44800.
    PubMed     Text format     Related articles    Abstract available


  250. JUNQUEIRA C , Guerrero AT, Galvao-Filho B, Andrade WA, et al
    Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine.
    PLoS One. 2012;7:e36245.
    PubMed     Text format     Related articles    Abstract available


  251. VAN RIKXOORT M , Michaelis M, Wolschek M, Muster T, et al
    Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame.
    PLoS One. 2012;7:e36506.
    PubMed     Text format     Related articles    Abstract available


  252. ENGESAETER B , Engebraaten O, Florenes VA, Maelandsmo GM, et al
    Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma.
    PLoS One. 2012;7:e45492.
    PubMed     Text format     Related articles    Abstract available


  253. MONTINARO A , Forte G, Sorrentino R, Luciano A, et al
    Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice.
    PLoS One. 2012;7:e45401.
    PubMed     Text format     Related articles    Abstract available


  254. NYLUND C , Rappu P, Pakula E, Heino A, et al
    Melanoma-Associated Cancer-Testis Antigen 16 (CT16) Regulates the Expression of Apoptotic and Antiapoptotic Genes and Promotes Cell Survival.
    PLoS One. 2012;7:e45382.
    PubMed     Text format     Related articles    Abstract available


  255. PAN T , Zhu J, Hwu WJ, Jankovic J, et al
    The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.
    PLoS One. 2012;7:e45183.
    PubMed     Text format     Related articles    Abstract available


  256. ZHANG G , Li G
    Novel multiple markers to distinguish melanoma from dysplastic nevi.
    PLoS One. 2012;7:e45037.
    PubMed     Text format     Related articles    Abstract available


  257. DE INGENIIS J , Ratnikov B, Richardson AD, Scott DA, et al
    Functional specialization in proline biosynthesis of melanoma.
    PLoS One. 2012;7:e45190.
    PubMed     Text format     Related articles    Abstract available


  258. SAFAEE ARDEKANI G , Jafarnejad SM, Tan L, Saeedi A, et al
    The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis.
    PLoS One. 2012;7:e47054.
    PubMed     Text format     Related articles    Abstract available


  259. XIAO D , Ohlendorf J, Chen Y, Taylor DD, et al
    Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes.
    PLoS One. 2012;7:e46874.
    PubMed     Text format     Related articles    Abstract available


  260. PAULITSCHKE V , Gruber S, Hofstatter E, Haudek-Prinz V, et al
    Proteome Analysis Identified the PPARgamma Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction.
    PLoS One. 2012;7:e46103.
    PubMed     Text format     Related articles    Abstract available


  261. ABUSHAHBA W , Olabisi OO, Jeong BS, Boregowda RK, et al
    Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma.
    PLoS One. 2012;7:e47312.
    PubMed     Text format     Related articles    Abstract available


  262. LEVY D , Davidovich A, Zirkin S, Frug Y, et al
    Activation of cell cycle arrest and apoptosis by the proto-oncogene Pim-2.
    PLoS One. 2012;7:e34736.
    PubMed     Text format     Related articles    Abstract available


  263. SCHARTL M , Kneitz S, Wilde B, Wagner T, et al
    Conserved expression signatures between medaka and human pigment cell tumors.
    PLoS One. 2012;7:e37880.
    PubMed     Text format     Related articles    Abstract available


  264. EBERT LM , Macraild SE, Zanker D, Davis ID, et al
    A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma.
    PLoS One. 2012;7:e48424.
    PubMed     Text format     Related articles    Abstract available


  265. DELLINGER RW , Matundan HH, Ahmed AS, Duong PH, et al
    Anti-Cancer Drugs Elicit Re-Expression of UDP-Glucuronosyltransferases in Melanoma Cells.
    PLoS One. 2012;7:e47696.
    PubMed     Text format     Related articles    Abstract available


  266. CESAREO E , Korkina L, D'Errico G, Vitiello G, et al
    An Endogenous Electron Spin Resonance (ESR) Signal Discriminates Nevi from Melanomas in Human Specimens: A Step Forward in Its Diagnostic Application.
    PLoS One. 2012;7:e48849.
    PubMed     Text format     Related articles    Abstract available


  267. GSCHAIDER M , Neumann F, Peters B, Lenz F, et al
    An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.
    PLoS One. 2012;7:e49865.
    PubMed     Text format     Related articles    Abstract available


  268. TIAN Y , Nam S, Liu L, Yakushijin F, et al
    Spirooxindole Derivative SOID-8 Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells.
    PLoS One. 2012;7:e49306.
    PubMed     Text format     Related articles    Abstract available


  269. WANG L , Shi Y, Ju P, Liu R, et al
    Silencing of diphthamide synthesis 3 (dph3) reduces metastasis of murine melanoma.
    PLoS One. 2012;7:e49988.
    PubMed     Text format     Related articles    Abstract available


  270. WEHBE M , Soudja SM, Mas A, Chasson L, et al
    Epithelial-Mesenchymal-Transition-Like and TGFbeta Pathways Associated with Autochthonous Inflammatory Melanoma Development in Mice.
    PLoS One. 2012;7:e49419.
    PubMed     Text format     Related articles    Abstract available


  271. LENCI RE , Bevier M, Brandt A, Bermejo JL, et al
    Influence of genetic variants in type I interferon genes on melanoma survival and therapy.
    PLoS One. 2012;7:e50692.
    PubMed     Text format     Related articles    Abstract available


  272. SALVIANTI F , Pinzani P, Verderio P, Ciniselli CM, et al
    Multiparametric analysis of cell-free DNA in melanoma patients.
    PLoS One. 2012;7:e49843.
    PubMed     Text format     Related articles    Abstract available


  273. CORDOVA A , Toia F, La Mendola C, Orlando V, et al
    Characterization of Human gammadelta T Lymphocytes Infiltrating Primary Malignant Melanomas.
    PLoS One. 2012;7:e49878.
    PubMed     Text format     Related articles    Abstract available


  274. BHATIA S , Moon J, Margolin KA, Weber JS, et al
    Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512.
    PLoS One. 2012;7:e48787.
    PubMed     Text format     Related articles    Abstract available


  275. OCHOA-ALVAREZ JA , Krishnan H, Shen Y, Acharya NK, et al
    Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.
    PLoS One. 2012;7:e41845.
    PubMed     Text format     Related articles    Abstract available


  276. SZEBENI GJ , Kriston-Pal E, Blazso P, Katona RL, et al
    Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion.
    PLoS One. 2012;7:e41372.
    PubMed     Text format     Related articles    Abstract available


  277. SCHAYOWITZ A , Bertenshaw G, Jeffries E, Schatz T, et al
    Functional profiling of live melanoma samples using a novel automated platform.
    PLoS One. 2012;7:e52760.
    PubMed     Text format     Related articles    Abstract available


  278. BOBINET M , Vignard V, Rogel A, Khammari A, et al
    MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients.
    PLoS One. 2012;7:e51716.
    PubMed     Text format     Related articles    Abstract available


  279. KNOL AC , Nguyen JM, Pandolfino MC, Quereux G, et al
    Tissue Biomarkers in Melanoma Patients Treated with TIL.
    PLoS One. 2012;7:e48729.
    PubMed     Text format     Related articles    Abstract available


  280. BODELON C , Pfeiffer RM, Bollati V, Debbache J, et al
    On the interplay of telomeres, nevi and the risk of melanoma.
    PLoS One. 2012;7:e52466.
    PubMed     Text format     Related articles    Abstract available


  281. ANGENIEUX C , Waharte F, Gidon A, Signorino-Gelo F, et al
    Lysosomal-associated transmembrane protein 5 (LAPTM5) is a molecular partner of CD1e.
    PLoS One. 2012;7:e42634.
    PubMed     Text format     Related articles    Abstract available


  282. BRUDER JM , Pfeiffer ZA, Ciriello JM, Horrigan DM, et al
    Melanosomal dynamics assessed with a live-cell fluorescent melanosomal marker.
    PLoS One. 2012;7:e43465.
    PubMed     Text format     Related articles    Abstract available


  283. HUANG X , Wang L, Zhang H, Wang H, et al
    Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.
    PLoS One. 2012;7:e44301.
    PubMed     Text format     Related articles    Abstract available


  284. MARIN MB , Ghenea S, Spiridon LN, Chiritoiu GN, et al
    Tyrosinase degradation is prevented when EDEM1 lacks the intrinsically disordered region.
    PLoS One. 2012;7:e42998.
    PubMed     Text format     Related articles    Abstract available


  285. HOFFMAN SJ , Psaltis PJ, Clark KJ, Spoon DB, et al
    An in vivo method to quantify lymphangiogenesis in zebrafish.
    PLoS One. 2012;7:e45240.
    PubMed     Text format     Related articles    Abstract available


  286. ZHAO RY , Mifsud NA, Xiao K, Chan KF, et al
    A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.
    PLoS One. 2012;7:e44707.
    PubMed     Text format     Related articles    Abstract available


  287. IBANEZ IL , Bracalente C, Notcovich C, Tropper I, et al
    Phosphorylation and subcellular localization of p27Kip1 regulated by hydrogen peroxide modulation in cancer cells.
    PLoS One. 2012;7:e44502.
    PubMed     Text format     Related articles    Abstract available


  288. HALE JS , Li M, Sinyuk M, Jahnen-Dechent W, et al
    Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
    PLoS One. 2012;7:e40033.
    PubMed     Text format     Related articles    Abstract available


  289. MURDOCH B , DelConte C, Garcia-Castro MI
    Pax7 lineage contributions to the mammalian neural crest.
    PLoS One. 2012;7:e41089.
    PubMed     Text format     Related articles    Abstract available


  290. CHEN J , Zhang L, Wen W, Hao J, et al
    Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice.
    PLoS One. 2012;7:e47219.
    PubMed     Text format     Related articles    Abstract available


  291. HE C , Qu X, Wan J, Rong R, et al
    Inhibiting delta-6 desaturase activity suppresses tumor growth in mice.
    PLoS One. 2012;7:e47567.
    PubMed     Text format     Related articles    Abstract available


  292. LARGHI P , Porta C, Riboldi E, Totaro MG, et al
    The p50 subunit of NF-kappaB orchestrates dendritic cell lifespan and activation of adaptive immunity.
    PLoS One. 2012;7:e45279.
    PubMed     Text format     Related articles    Abstract available


    January 2011
  293. GRIL B , Palmieri D, Qian Y, Anwar T, et al
    The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models.
    PLoS One. 2011;6:e25625.
    PubMed     Text format     Related articles    Abstract available


  294. AGUZZI MS , D'Arcangelo D, Giampietri C, Capogrossi MC, et al
    RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.
    PLoS One. 2011;6:e25352.
    PubMed     Text format     Related articles    Abstract available


  295. MADSEN L , Kriegenburg F, Vala A, Best D, et al
    The tissue-specific Rep8/UBXD6 tethers p97 to the endoplasmic reticulum membrane for degradation of misfolded proteins.
    PLoS One. 2011;6:e25061.
    PubMed     Text format     Related articles    Abstract available


  296. MAZAR J , Khaitan D, DeBlasio D, Zhong C, et al
    Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.
    PLoS One. 2011;6:e24922.
    PubMed     Text format     Related articles    Abstract available


  297. GAST A , Bermejo JL, Claus R, Brandt A, et al
    Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival.
    PLoS One. 2011;6:e24370.
    PubMed     Text format     Related articles    Abstract available


  298. EIDSON M , Wahlstrom J, Beaulieu AM, Zaidi B, et al
    Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient.
    PLoS One. 2011;6:e24441.
    PubMed     Text format     Related articles    Abstract available


  299. RISBERG K , Fodstad O, Andersson Y
    Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.
    PLoS One. 2011;6:e24012.
    PubMed     Text format     Related articles    Abstract available


  300. SINNBERG T , Menzel M, Ewerth D, Sauer B, et al
    beta-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.
    PLoS One. 2011;6:e23429.
    PubMed     Text format     Related articles    Abstract available


  301. KUMAGAI A , Horike N, Satoh Y, Uebi T, et al
    A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells.
    PLoS One. 2011;6:e26148.
    PubMed     Text format     Related articles    Abstract available


  302. SINGH T , Katiyar SK
    Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
    PLoS One. 2011;6:e25224.
    PubMed     Text format     Related articles    Abstract available


  303. PAPPALARDO F , Martinez Forero I, Pennisi M, Palazon A, et al
    SimB16: modeling induced immune system response against B16-melanoma.
    PLoS One. 2011;6:e26523.
    PubMed     Text format     Related articles    Abstract available


  304. BONAZZI VF , Nancarrow DJ, Stark MS, Moser RJ, et al
    Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.
    PLoS One. 2011;6:e26121.
    PubMed     Text format     Related articles    Abstract available


  305. ESSLER M , Link A, Belloni B, Mirceva V, et al
    Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma.
    PLoS One. 2011;6:e24632.
    PubMed     Text format     Related articles    Abstract available


  306. YAN J , Wang ZY, Yang HZ, Liu HZ, et al
    Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNgamma/STAT1-mediated activation of autophagy.
    PLoS One. 2011;6:e24705.
    PubMed     Text format     Related articles    Abstract available


  307. AHMAD F , Mani J, Kumar P, Haridas S, et al
    Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.
    PLoS One. 2011;6:e25424.
    PubMed     Text format     Related articles    Abstract available


  308. HUYNH C , Poliseno L, Segura MF, Medicherla R, et al
    The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma.
    PLoS One. 2011;6:e25264.
    PubMed     Text format     Related articles    Abstract available


  309. LUCIO KA , Rocha Gda G, Moncao-Ribeiro LC, Fernandes J, et al
    Oleanolic Acid Initiates Apoptosis in Non-Small Cell Lung Cancer Cell Lines and Reduces Metastasis of a B16F10 Melanoma Model In Vivo.
    PLoS One. 2011;6:e28596.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: